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Abstract Pseudomonas species strain SBV1 can rapidly
grow on medium containing β-valine as a sole nitrogen
source. The tertiary amine feature of β-valine prevents direct
deamination reactions catalyzed by aminotransferases, amino
acid dehydrogenases, and amino acid oxidases. However,
lyase- or aminomutase-mediated conversions would be possi-
ble. To identify enzymes involved in the degradation of β-
valine, a PsSBV1 gene library was prepared and used to com-
plement the β-valine growth deficiency of a closely related
Pseudomonas strain. This resulted in the identification of a
gene encoding β-valinyl-coenzyme A ligase (BvaA) and two
genes encoding β-valinyl-CoA ammonia lyases (BvaB1 and
BvaB2). The BvaA protein demonstrated high sequence iden-
tity to several known phenylacetate CoA ligases. Purified
BvaA enzyme did not convert phenyl acetic acid but was able
to activate β-valine in an adenosine triphosphate (ATP)- and
CoA-dependent manner. The substrate range of the enzyme
appears to be narrow, converting only β-valine and to a lesser
extent, 3-aminobutyrate and β-alanine. Characterization of
BvaB1 and BvaB2 revealed that both enzymes were able to
deaminate β-valinyl-CoA to produce 3-methylcrotonyl-CoA,
a common intermediate in the leucine degradation pathway.
Interestingly, BvaB1 and BvaB2 demonstrated no significant
sequence identity to known CoA-dependent ammonia lyases,
suggesting they belong to a new family of enzymes. BLAST
searches revealed that BvaB1 and BvaB2 show high sequence
identity to each other and to several enoyl-CoA hydratases, a
class of enzymes that catalyze a similar reaction with water
instead of amine as the leaving group.
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Introduction
Whereas the microbial metabolism of α-amino acids is well
known, the bioconversion of β-amino acids leaves a wide
spectrum of metabolic exploration. More insight into the en-
zymology of β-amino acid metabolism is desirable since it can
lead to the discovery of enzymes that can be used in applied
biocatalysis or incorporated in biosynthetic pathways. In this
study, we aimed to understand the deamination mechanism of
β-valine. For α-valine and other α-amino acids, several con-
version types are described in the literature (Fernández and
Zúñiga 2006; Massey et al. 1976). The most common en-
zymes in aliphatic amino acid (de)amination reactions include
aminotransferases, amino acid dehydrogenases, and amino
acid oxidases. Although these enzymes use different mecha-
nisms for substrate deamination, all form a keto-product.
Substrates such as β-valine that carry the amino group on a
tertiary carbon atom cannot be deaminated by these enzymes
due to the lack of a carbon-hydrogen bond. Consequently, it
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was expected that unusual deamination mechanisms could
operate on these substrates.
The first step in the deamination ofβ-valine can be performed
by an aminomutase, resulting in an α-amino acid that is deam-
inated by one of the common reactions mentioned above.
Aminomutases catalyze a reversible intra-molecular amino
group migration between vicinal carbon atoms. These enzymes
are involved in processes such as the anaerobic biodegradation
of lysine and the biosynthesis of several biologically active sec-
ondary metabolites, such as antibiotics (Walker et al. 2004; Yin
et al. 2003). Aminomutase reactions proceed with the direct
involvement of several cofactors, such as S-adenosylmethionine
(SAM), [4Fe-4S] clusters, pyridoxal-5′-phosphate (PLP), coen-
zyme B12, or 4-methylideneimidazole-5-one (MIO) (Heberling
et al. 2013; Wu et al. 2011; Frey and Reed 2011).
Deamination of β-valine can possibly also occur by a lyase
reaction, with formation of the corresponding enoate. These
reactions are well known for amino acid deamination; the
most common examples being aspartase, methylaspartate am-
monia lyase, and MIO-dependent ammonia lyases. Although
these enzymes are structurally and mechanistically quite dif-
ferent, they all are restricted to substrates containing a carbox-
ylate group in combination with an aromatic group (histidine,
phenylalanine, and tyrosine ammonia lyases) or a second car-
boxylate (aspartase and aspartate ammonia lyase). These
structural commonalities are explained by the need to delocal-
ize negative charge to a carboxylate or aromatic function-
ality that is beta-positioned with respect to the carbon
from which the amino group is eliminated. So far, these
lyase reactions are not known to occur directly on amino
acids that carry only a single carboxylate (such as valine
or leucine) or β-amino acids (such as 3-aminobutyrate or
β-alanine) (Bartsch et al. 2013).
Another possibility is that β-valine deamination is depen-
dent on activation by conversion to a coenzyme A (CoA)-
thioester, as described for the metabolism of β-alanine and
α-lysine (Herrmann et al. 2005; Kreimeyer et al. 2007). β-
Alanine is a naturally occurring β-amino acid found in vitamin
B5 (pantothenic acid). In the metabolic degradation pathway,
β-alanine is first activated by CoA in a reaction catalyzed by
β-alanyl-CoA-transferase. Ammonia is then eliminated in a
reaction catalyzed by β-alanyl-CoA/ammonia lyase
(Herrmann et al. 2005). Additionally, anaerobic metabolism
of α-lysine proceeds via several reactions yielding 5-amino-3-
oxohexanoate. This reacts with acetyl-CoA resulting in
acetoacetate and 3-aminobutyryl-CoA, which is successively
deaminated to crotonyl-CoA by 3-aminobutyryl-CoA deami-
nase (Kreimeyer et al. 2007).
In this study, the deamination of β-valine was studied in
detail using the newly isolated β-valine-degrading microor-
ganism Pseudomonas sp. strain SBV1, to potentially discover
a novel pathway for β-amino acid deamination. This study
revealed that metabolism of β-valine is dependent on the β-
valinyl-CoA ligase BvaA and the two novel CoA-dependent
ammonia lyases BvaB1 and BvaB2.
Materials and methods
Strains and chemicals
Escherichia coli TOP10, MC1061, and C41(DE3) were pur-
chased from Invitrogen. Pseudomonas fluorescens Pf0-1 was
kindly provided by Prof. M.W. Silby (University of
Massachusetts Dartmouth, USA) and P. fluorescens Pf-5
was obtained from American Type Culture Collection
(ATCC). The β-valine degrading bacterium SBV1 (DSMZ,
accession number DSM 29543) was isolated from residential
grass soil (The Netherlands), by growth selection on YCB
medium containing β-valine as a sole nitrogen source.
Adenosine monophosphate (AMP), adenosine diphosphate
(ADP), adenosine triphosphate (ATP), CoA (trilithium salt),
and isopropyl-β-D-thiogalactoside (IPTG) were obtained from
Sigma. β-Valine was purchased from Fluorochem (Germany).
DL-α-valine and α-ketoglutarate (disodium salt) were pur-
chased from Fluka. The protease inhibitor cocktail complete
(EDTA-free) was bought from Roche. Restriction enzymes
were purchased fromNew England BioLabs and used accord-
ing to the manufacturer’s protocol.
Cultivation conditions
E. coli cells were grown at 37 °C in LB medium (Sambrook
et al. 2001) or M9medium (Sigma) containing 2 mMMgSO4,
0.4 % glucose, 0.1 mM CaCl2, 0.02 % thiamine, and 1 %
casamino acids. P. fluorescens cells were grown at 30 °C on
LB, nutrient broth (NB; Sigma), or nitrogen-free minimal me-
dium (MM) (Gabor et al. 2004), supplemented with citrate
(10 mM) or glucose (0.2 %) as carbon source and (NH4)SO4
or β-valine (5–10 mM) as nitrogen source. When required,
leucine (5 μg/mL) and ampicillin (50 μg/mL) or tetracycline
(12.5 μg/mL) were added to the media. For the preparation of
agar plates, the medium was supplemented with 2 % agar or
1.5 % agarose, rinsed with H2O.
Plasmid construction
Primers are listed in Table S1. The pBADNK plasmid is a
pBAD/MycHisA-derived expression vector (Invitrogen) in
which the NdeI site is removed and the NcoI site is replaced
by NdeI.
For the purification of BvaA, plasmid pBad-bvaA-his was
constructed containing an in-frame fusion of the bvaA gene to
a Myc-His-tag, behind the araBAD promoter region. For this
purpose, the bvaA gene was amplified from plasmid p4-D1
(described in this paper) and primers Lig_fw and Lig_rev. The
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resulting product, lacking the stop codon of the bvaA gene,
was then digested with NdeI and XhoI, and ligated into NdeI-
XhoI-digested pBADNK.
For the purification of BvaB1 and BvaB2, plasmids pET-
bvaB1-his and pET-bvaB2-his were constructed containing an
in-frame fusion of either the bvaB1 or the bvaB2 gene to a His-
tag behind the T7 promoter. To this purpose, the bvaB1 and
the bvaB2 genes were amplified using plasmid p4-D1 and
either primers LyS2_fw and LyS2_rev or LyS3_fw and
LyS3_rev. The resulting products, lacking the stop codon of
the genes, was then digested with NdeI and XhoI, and ligated
into NdeI-XhoI-digested pET21a (Agilent).
Cosmid library generation and screening
Genomic DNA of SBV1 cells was partially digested with
Sau3AI to an average fragment size of 20–30 kb. Fragments
were ligated into the BamHI-linearized cosmid cloning vector
pLAFR3 (Friedman et al. 1982). Packaging was done in
phage particles using the Gigapack III-XL kit according to
the instructions of the manufacturer (Agilent). Phage particles
were transfected to E. coli TOP10 cells, and clones were se-
lected on LB agar with tetracycline.
Triparental mating (Ditta et al. 1980) was carried out by
replica plating donor cells on LB-agar plates treated with an
exponentially growing culture of the helper strain E. coli
HB101(pRK600) (Kessler et al. 1992). After overnight incu-
bation, these plates were replica plated onto NB-agar plates
treated with an overnight-grown NB culture of the recipient
strain P. fluorescens Pf0-1. The plates were incubated over-
night at 30 °C, after which transconjugants were selected by
replica-plating onto MM agarose plates containing 5 mM so-
dium citrate, 10 mM ammonium sulfate, and tetracycline.
To select potential P. fluorescens Pf0-1 clones that were
complemented for their growth deficiency, all transconjugants
were replica-plated to agarose plates containing 5 mM citrate
and 10 mM β-valine as sole carbon and nitrogen sources.
Positive clones were identified based on the ability to form a
clearly visible colony on this medium. To test whether identi-
fied positive clones were able to produce ammonia from sub-
strate, transconjugants were tested by an ammonia release
assay (Berthelot assay, Fawcett and Scott 1960). For this pur-
pose, a small amount of cell material was transferred from a
fresh NB plate to a microtiter plate (MTP) well containing
150 μl of 5 mM β-valine in 20 mM KPi buffer (pH 7.5).
The MTP was covered with BreathSeal (GE Healthcare) and
incubated overnight in a tabletop MTP shaker at 30 °C. The
cells were centrifuged and to 20 μl of supernatant, 30 μl of
0.025 % phenol (vol/vol) in 0.3 N NaOH, 30 μl of 0.01 %
sodium nitroprusside, and 30 μl of 20 mM NaOCl were
added. This mixture was incubated for 15 min at 30 °C.
Production of free ammonia by P. fluorescens Pf0-1 clones
was detected by the appearance of a blue color.
DNA sequencing
For the identification of strain SBV1, the 16S ribosomal RNA
(rRNA) gene was amplified using primers 27F and 1492R
(Table S1). The resulting product was subsequently purified
using the PCR Purification Kit (Qiagen) and sequenced by
GATC Biotech. The nucleotide sequence was deposited at
GenBank (accession number KM657826). Subsequent iden-
tification was performed online, using the EzTaxon database
(Chun et al. 2007).
In order to obtain a partial sequence of the SBV1 genome,
total genomic DNA from SBV1 cells grown on MM contain-
ing 10 mM β-valine and 20 mM glucose was isolated accord-
ing to a described procedure (Poelarends et al. 1998). The
resulting genomic DNAwas subjected to paired-end sequenc-
ing by Baseclear BV. The genome sequencing was done using
an Illumina (Solexa) GAIIx Genome Analyzer. Sequencing
yielded 7.2 million reads of ~50 bp. These were assembled
using the CLC Genomics Workbench software, resulting in
996 contigs with a total length of 6,440,520 bp.
Sequencing of pLAFR3 inserts from specific P. fluorescens
Pf0-1 transconjugants was done at GATC Biotech, using var-
ious primers. The complete insert sequence of p4-D1 was
assembled by combining the contigs of the partial genome
sequence and primer walking (GATC Biotech), resulting in a
sequence of 25,618 bp (GenBank accession number
KM595283).
Expression and purification
For expression of BvaA-His, an overnight culture of E. coli
MC1061 containing pBAD-bvaA-his was 100-fold diluted in
M9 medium and incubated at 37 °C in a rotary shaker. When
the culture reached an OD600 of ~0.6, arabinose (0.02 %) was
added to the medium and the culture was incubated for an
additional 64 h at 17 °C.
For expression of BvaB1-His or BvaB2-His, an overnight
culture of E. coli C41(DE3) containing pET-bvaB1-his or
pET-bvaB2-his was 100 times diluted in LB medium and
incubated at 37 °C in a rotary shaker. When the culture
reached an OD600 of ~0.6, 0.5 mM IPTG was added to the
medium and the culture was incubated for an additional 16 h
at 30 °C.
For the purification of BvaA-His enzyme to 40–50 %
purity and BvaB1-His or BvaB2-His enzyme to more than
90 % purity, cells were harvested by centrifugation
(20 min, 6000×g, 4 °C). Subsequently, cells were resus-
pended in buffer I (50 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 500 mM NaCl,
20 mM imidazole, pH 8, protease inhibitor cocktail) and
lysed by sonication. To remove unbroken cells and cell
debris, lysates were centrifuged at 30,000×g for 45 min.
The extracts were separated on a 5-ml Hi-trap (GE
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Healthcare) column connected to an Äkta purifier, and the
proteins were eluted using increasing concentrations of
elution buffer (50 mM HEPES, 500 mM NaCl, 50 mM
imidazole, pH 8). The imidazole was removed using an
EconoPac 10DG desalting column (Bio-Rad) against buff-
er II (20 mM HEPES, 150 mM NaCl, 10 % glycerol,
pH 8). Enzyme concentrations were determined using
Bradford reagent.
Enzyme activity assays
CoA ligase activity towards β-valine was determined by fol-
lowing the substrate-dependent formation of AMP by reverse-
phase high-performance liquid chromatography (HPLC).
Standard reaction mixtures contained 50 mM HEPES
(pH 8), 150 mM NaCl, 5 mM MgCl2, 5 mM ATP, 2.5 mM
CoA, 2.5 mM β-valine, and 0.7 mg/ml BvaA-His in a total
volume of 500 μl. Reactions were carried out at 30 °C.
Samples were taken and quenched by addition of 0.8% formic
acid. Levels of AMP, ADP, ATP, CoA and β-valinyl-CoA
were determined by HPLC using a Gemini C18 column
(5 μm particle size, 250×4.6 mm), connected to a Jasco UV-
2075 detector set at 254 nm. Compounds were eluted using
buffer A (25 mM KH2PO4, 2.5 % triethylamine, set to pH 6.5
using H3PO4, and 5 % methanol) with a gradually increas-
ing concentration of elution buffer B (buffer A with 50 %
methanol; 0–2 min, 0 %; 2–20 min, 0–46 %; 20–30 min,
46–100 %; 30–32 min, 100 %; 32–35 min, 100–0 %; 35–
45 min, 0 % of eluent B). Typical retention times were
10 min for AMP, 12 min for ADP, 13 min for ATP,
23 min for β-valinyl-CoA, 24 min for CoA, and 36 min
for methyl-crotonyl-CoA.
Lyase activity was determined by monitoring enzyme-
specific depletion of β-valinyl-CoA. Since no pure CoA-
adduct was available, the level of β-valinyl-CoAwas calculated
based on the assumption that during the CoA ligase reaction,
1 mM substrate-dependent AMP release corresponds to 1 mM
of β-valinyl-CoA product. Additionally, the level of
methylcrotonyl-CoA was calculated based on the assumption
that during the ammonia lyase reaction the substrate-dependent
reduction of 1mM β-valinyl-CoA corresponds to the formation
of 1 mM of methyl-crotonyl-CoA product. For the analyses, β-
valinyl-CoAwas first produced in a reaction mixture contain-
ing 50 mM HEPES (pH 8), 150 mM NaCl, 5 mM MgCl2,
5 mM ATP, 2.5 mM CoA, 2.5 mM β-valine, and 0.7 mg/ml
BvaA-His, in a total volume of 500 μl. After an incubation of
16 h at 30 °C, the samples were filtered to remove all ligase
using Amicon Ultra-0.5 ml centrifugal filters (10 K, Merck
Millipore). Subsequently, 0.025 mg/ml BvaB1-His or BvaB2-
His was added to the samples. After different time intervals,
enzymatic conversions in the samples were quenched by the
addition of 0.8 % formic acid and samples were analyzed by
reverse-HPLC analysis as described above.
HPLC-MS
Identification of β-valinyl-CoA and methyl-crotonyl-CoA
was performed in a LCQ Fleet Ion Trap mass spectrometer
(Thermo Scientific). Reaction components were separated by
HPLC using an Alltech Altima HP C18 column (3 μm, 100×
2.1 mm). The CoA adducts were eluted using eluent A (water,
0.1 % formic acid) with an elution gradient of eluent B (ace-
tonitrile, 0.08 % formic acid; 0–2 min, 0–2 %; 2–20 min, 2–
15 %; 20–32 min, 15–80 %; 32–37 min, 80 %; 37–38 min, 80
0 %; 38–48min, 0 % eluent B). The samples were analyzed in
a negative ion mode, and mass spectra were collected over a
scan range of m/z 500–1000. Typical retention times were
13 min for β-valinyl-CoA (m/z 864; M–H) and 28 min for
methyl-crotonyl-CoA (m/z 847; M–H).
UPLC-MS
To explore the substrate scope of the CoA ligase BvaA,
the formation of aminoacyl-CoAs was analyzed by an
Acquity TQD mass spectrometer (Waters). Reaction mix-
tures containing 2.5 mM of different substrates and CoA li-
gase were prepared, as described before. Substrates used in
this assay included: β-valine, β-alanine, α-valine,
phenylacetic acid, β-phenylalanine, β-glutamic acid, β-lysine,
D-phenylalanine, L-phenylalanine, D-tyrosine, L-tyrosine, L-al-
anine, L-leucine, isoleucine, L-lysine, acetate, hexanoic acid,
heptanoic acid, octanoic acid, benzoic acid, 4-chlorobenzoate,
3-aminobutyrate, and 2-aminoisobutyrate. Samples were tak-
en and quenched by addition of 0.8 % formic acid.
Subsequently, separation of the reaction components was per-
formed by UPLC using an Acquity UPLC HSS T3 Column
(1.8 μm, 2.1×150 mm). The components were eluted using a
linear gradient (eluent A; water, 0.1 % FA, eluent B; 100
acetonitrile, 0.1 % FA). The samples were analyzed in a neg-
ative ion mode, and mass spectra were collected over a scan
range of m/z 600–1100.
Homology modeling
For the construction of a homology model of BvaA, the Phyre
on-line server was used (Kelley and Sternberg 2009). To con-
struct homology models of BvaB1 and BvaB2, the YASARA
software (www.yasara.org) was used. Phyre selected the PDB
structure of the hypothetical acyl-CoA ligase 3QOV as tem-
plate for BvaA. YASARA constructed models of BvaB1 and
BvaB2 based on the structure of the rat liver enoyl hydratase
that was complexed with the inhibitor acetoacetyl-CoA (PDB
1DUB, Engel et al. 1996). Homologymodeling of BvaB1 and
BvaB2 was performed with the substrate β-valinyl-CoA
bound in the active site. Comparison of the structures
and preparation of the figures was performed using
Pymol software (www.pymol.org).
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MD simulations were carried out with the enzyme com-
plexed with a transition state-like structure of the β-valinyl-
CoA substrate (BvaB1, BvaB2) or the 3-amino-butyryl-CoA
substrate (rat liver enoyl hydratase). This approach allows
direct monitoring of residues that interact with the transition
state and thereby lower the energy barrier for reaching the
transition state (Gao et al. 2006; Pan et al. 2005; Zheng et al.
2008). To enable MD simulation of a transition state-like
structure, distance restraints have to be used to prevent the
structure from collapsing to the substrate or product structures
which are lower in energy (Gao et al. 2006; Pan et al. 2005;
Zheng et al. 2008; Xue et al. 2011). Angles and dihedrals were
not constrained because these were not expected to differ sig-
nificantly between substrates, transition state, and product.
Since no quantum-mechanical modeling was available, the
distances were constrained to the average of the corresponding
distances in the substrate and product states, which should be
sufficiently accurate as the difference with quantum mechan-
ical calculations will only be tenths of an Ångström (Å). The
distance between the β-valinyl-CoA nitrogen atom of the
amine and the electrophilic carbon atom was set to 2.36 Å,
which is the average of the Van der Waals contact distance
(3.25 Å) and the length of a C–N bond (1.47 Å). Since the
catalytic mechanism of BvaB1 and BvaB2 is expected to be
similar to that of enoyl hydratases (Engel et al. 1996), which
catalyze a dehydration of hydroxyesters instead of deamina-
tion of amino acids, the conserved Glu144 (Bca1 numbering)
contributes to catalysis by stabilizing negative charge devel-
oping on the nitrogen atom of the β-valinyl-CoA moiety via
hydrogen bonding while Glu164 will donate a proton to the
leaving group amine. Therefore, the distance between Glu144
OE1 and the β-Val NHD1 hydrogen atom was constrained at
2.0 Å, similar to the length of a strong H-bond between a
lysine and a glutamate (Musafia et al. 1995), and the distance
between OE1 of Glu164 and the β-Val NHD1 hydrogen atom
was set to 1.5 Å, which is in between the length of a strong H-
bond and the length of a covalent N–H-bond (1.0 Å). These
distances were constrained with a force constant of
200 N m−1. For simulations of the transition state with water
attacking, the corresponding distances were 2.0 Å for the H-
bond between the N-terminal Glu144 side chain oxygen and
the nearest hydrogen atom of the water; 1.48 Å for the H-bond
with the C-terminal Glu164, and 2.32 Å for the distance be-
tween the leaving group oxygen atom and the carbon atom to
which it is covalently attached.
To carry out the MD simulations, either the obtained ho-
mology model or the X-ray structure of an enoylhydratase
(PDB accession 1DUB) was used to prepare structures with
the CoA thioester substrates bound together with the nucleo-
philes, ammonia, or water. Molecular dynamics (MD) simu-
lations were carried with a leap-frog propagation scheme and
a Berendsen thermostat in a rectangular simulation cell
(Berendsen et al. 1984). The simulation cell extended around
the protein at least 7.5 Å on each side and was filled with
explicit water molecules and sodium chloride counter ions to
a concentration of 0.5 %. The boundary conditions were pe-
riodic, the employed force field was Yamber3, and long range
electrostatics (>7.86 Å) were calculated with a particle Mesh
Ewald algorithms using fourth degree B-spline functions
(Krieger et al. 2004; Essmann et al. 1995). After an energy
minimization of the simulation box, each transition state-
enzyme complex was subjected to three MD simulations that
started with different initial atom velocities to create indepen-
dent trajectories. The protein was heated from 5 to 298 K in
the first 30 ps of the MD trajectory. The MD simulations were
allowed to continue for another 70 ps at 298 K and from the
last 50 ps, snapshots were collected to create an average
structure that was visually inspected. Additional details
of the protocol to carry out the MD simulations were
published previously (Wijma et al. 2014).
Results
Isolation of bacterial strains using β-valine as a sole
nitrogen source
In order to identify enzymes involved in the deamination of β-
amino acids, microorganisms were enriched from garden soil
by growth selection on medium containing β-valine as a sole
nitrogen source. This resulted in the isolation of a bacterium
termed SBV1. To confirm growth of strain SBV1 with
β-valine as the sole nitrogen source, cells were cultured on
minimal media (MM) supplemented with 30 mM glucose
and 10 mM β-valine as sole carbon and nitrogen sources,
respectively. Subsequently, β-valine levels were analyzed dur-
ing cell growth using HPLC with UV detection at 210 nm.
This revealed that SBV1 cells are able to degrade β-valine
with a maximum growth rate of ~0.2 h−1 (Fig. S1).
To identify strain SBV1, the 16S rRNA gene was se-
quenced. The resulting nucleotide sequence was deposited at
GenBank (accession number KM657826). A BLAST search
using the partial 16S rRNAgene sequence revealed that SBV1
is a Pseudomonas species, closely related to Pseudomonas
avellanae (99.1 % identity) and Pseudomonas mandelii
(98.9 % identity). The isolate was deposited in the German
Collection of Microorganisms and Cell Cultures (DSMZ, ac-
cession number DSM 29543).
Identification of a putative β-valine degradation gene
cluster
For the identification of enzymes required for β-valine degra-
dation in SBV1 cells, total protein extracts of SBV1 cells were
analyzed for the presence of proteins with induced expression
on medium supplemented with β-valine. SDS-PAGE analyses
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of protein extracts from β-valine-grown SBV1 cells and
ammonium-grown SBV1 cells revealed no significant differ-
ence indicating low expression levels of inducible β-valine
degradation genes (data not shown).
Next, a genetic approach was followed. Genomic DNA of
SBV1 cells was isolated and a partial genome sequence was
determined by paired-end sequencing. Using a BLAST
search, it appeared that the SBV1 genome is very similar to
that of P. fluorescens Pf-5 and P. fluorescens Pf0-1. Growth
assays revealed that both of these strains were not able to grow
on medium supplemented with β-valine as a sole nitrogen
source within 3 weeks, suggesting that although these strains
are very similar on the genetic level, they lack the enzymes for
β-valine metabolism.
To identify genes that are necessary for β-valine degrada-
tion in SBV1 cells, a SBV1 genome library was constructed in
E. coli. For this purpose, genomic DNA of SBV1 cells was
sheared to produce fragments of 20–30 kb, which were sub-
sequently ligated into the cosmid vector pLAFR3. Screening
of 2300 clones of the cosmid library in E. coli did not result in
the identification of a clone that was able to grow on solid
medium supplemented with β-valine after 3 weeks of incuba-
tion at 30 °C. Subsequent screening of the cosmid library in
P. fluorescens Pf0-1 on plates containing β-valine and citrate
resulted in two clones that were able to grow on this medium,
called p5-F12 and p4-D1. An ammonia release assay using
whole cells revealed that both clones produced free ammonia
during growth on β-valine as a sole nitrogen source.
Sequencing of the flanking regions from both inserts in
combination with the available partial genomic informa-
tion revealed that clones p5-F12 and p4-D1 contained a
similar genomic fragment. The complete insert sequence
of p4-D1 was assembled by combining the contigs of the
partial genome sequence and primer walking, resulting in
a sequence of 25,618 bp (Fig. 1a). The nucleotide se-
quence was deposited at GenBank (accession number
KM595283).
Sequence analysis revealed the presence of 18 open read-
ing frames (ORFs; Table 1; Fig. 1b). Interestingly, BLAST
searches revealed that many ORFs encode CoA-dependent
enzymes, among which several enzymes known to be in-
volved in the leucine catabolic pathway. Based on this, a hy-
pothetical pathway for β-valine metabolism in strain SBV1
was proposed, which partially overlaps with the leucine deg-
radation pathway (Fig. 1b).
Hypothetical β-valine degradation pathway
To enable growth on β-valine, uptake of β-valine may be
facilitated by the transport protein encoded by ORF7.
Inside the cell, β-valine may be activated by CoA in an
ATP-dependent reaction catalyzed by a CoA-dependent
ligase. Inspection of the insert for the presence of CoA
ligase related sequences resulted in the identification of
one ORF, ORF8. Database searches of the protein
encoded by ORF8 r evea l ed homo logy t o t h e
Burkholderia cenocepacia phenylacetate CoA ligase
Paak1 (2Y4N, 35 % identity) and the Pseudomonas
putida phenylacetate CoA Ligase (35 % identity). These
enzymes catalyze the conversion of phenylacetic acid to
phenylacetyl-CoA.
Subsequently, the β-valinyl-CoA adduct might be de-
aminated by an aminoacyl-CoA ammonia lyase, forming
3-methyl-crotonyl-CoA, a common intermediary metabo-
lite in the leucine degradation pathway (Aguilar et al.
2006). No ammonia lyases that are active on β-
aminoacyl-CoA have been described in the literature, with
the exception of a β-alanine CoA ammonia lyase (Acl1 and
Acl2; Herrmann et al. 2005) and 3-aminobutyryl-CoA ly-
ase (Kreimeyer et al. 2007). Inspection of the insert for the
presence of a homolog of this type of lyase did not result in
the identification of such an ORF. However, further inspec-
tion of the sequenced region showed the presence of two
ORFs (ORF9 and ORF12), which are highly similar (55 %
DNA sequence identity) and homologous to genes
encoding enzymes that belong to the family of enoyl
CoA hydratases. Enoyl CoA hydratases catalyze the re-
versible hydration of the double bond of a 2-enoyl-CoA
thioester, resulting in the formation of a β-hydroxyacyl-
CoA thioester (Agnihotri and Liu 2003). Database searches
with the protein sequence encoded by ORF9 revealed ho-
mology to Metallosphaera sedula 3-hydroxypropionyl-
CoA dehydratase (34 % identity), an enzyme that converts
3-hydroxypropionyl-CoA to acryloyl-CoA (Teufel et al.
2009). Additionally, the protein revealed homology to the
Thermus thermophilus PaaG (35 % identity), a predicted 2,
3-dehydroadipyl-CoA hydratase of which the structure is
solved (PDB 3HRX). Database searches of the protein
encoded by ORF12 showed homology to Mycobacterium
avium carnitinyl-CoA hydratase (3R0O; 48 % identity) and
the Proteus sp. carnitinyl-CoA dehydratase (34 %), an en-
zyme that converts crotonobetainyl-CoA to L-carnitinyl-
CoA (Engemann et al. 2001). Since some hydratases and
ammonia lyases are structurally similar (e.g., fumarase and
aspartate ammonia lyase; Puthan Veetil et al. 2012), it is
conceivable that a hydratase-like protein encoded by one
or both of these ORFs is involved in the deamination step.
Finally, the product 3-methyl-crotonyl-CoA can enter the
leucine degradation pathway where it will undergo a carbox-
ylation reaction to form to 3-methyl-glutaconyl-CoA. This
reaction is catalyzed by 3-methyl-crotonyl-CoA carboxylase
(ORF4, ORF6; Huang et al. 2011). In the next step, 3-methyl-
glutaconyl-CoA can be hydrated by a hydratase (ORF5),
forming 3-hydroxy-3-methylglutaryl-CoA. In the last step,
the latter metabolite can be cleaved into acetyl-CoA and
acetoacetate by hydroxymethylglutaryl-CoA lyase (ORF3).
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Characterization of BvaA
For the purification of the putative β-valinyl-CoA ligase
encoded by ORF8, a C-terminal His6-tag version of this en-
zyme, named BvaA-His, was expressed in E. coli. A protein of
the expected size was produced in low amounts, and most of it
was present in the soluble fraction. Enzyme purification using
Ni-NTA resin yielded ~2 mg purified enzyme/l of culture.
UPLC-MS analyses were performed to detect the formation
of the β-valinyl-CoA adduct in amixture containing ATP, CoA,
β-valine, and BvaA-His. After 16 h of incubation at 30 °C, the
presence of a parent ion of the expected size in a single proton-
ated form was detected (Fig. 2a). Subsequently, levels of AMP,
ADP, ATP, CoA, and β-valinyl-CoAwere monitored in time by
HPLC (Fig. 2b). This demonstrated that both the β-valinyl-
CoA and the AMP levels increased in time. Calculation of
the specific activity, based on substrate-dependent AMP pro-
duction, revealed a rate of approximately 10 mU/mg.
To confirm that BvaA functions in β-valine activation, β-
valinyl-CoA production was determined using protein extracts
of various strains, including the β-valine growth-deficient
strain P. fluorescens Pf0-1 (Pf-WT) and the β-valine-degrading
organisms SBV1 and Pf0-1 containing the bvaA gene on the
complementing plasmid p4-D1 (Pf-Comp). SBV1 protein ex-
tracts were used as a positive control. Cells were grown for 24 h
on MM supplemented with a mixture of 2 mM ammonium
sulfate and 5 mM β-valine as nitrogen sources. Subsequently,
cell-free extracts of these cells were incubated in the presence
of β-valine, CoA and ATP, and levels of produced β-valinyl-
CoAwere determined by HPLC (Fig. 3). This revealed that in
cell-free extracts of β-valine-grown SBV1 cells already a low
level of β-valinyl-CoA is present. After 2 h of incubation, β-
valinyl-CoA levels were increased approximately 17-fold.
Longer incubations did not increase the levels any further.
Analyses of β-valinyl-CoA levels in samples containing pro-
tein extracts prepared from pf 0–1 cells revealed that β-valinyl-
Fig. 1 a Schematic
representation of the organization
of the ORFs identified in the
26,347 bp insert of plasmid p4-
D1. b Proposed degradation
pathway of β-valine by
Pseudomonas sp. SBV1. The
boxed region represents the
putative initial steps in the β-
valine degradation pathway,
resulting in formation of 3-
methyl-crotonyl-CoA, a common
intermediate in the leucine
degradation pathway, represented
in the lower part. ORFs that are
putatively important for β-valine
degradation based on homology
to enzymes with known function
(Table 1) are numbered
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CoA is produced in time, but only in protein extracts prepared
from cells containing plasmid p4D1 (Fig. 3). Taken together,
this strongly implicates the bvaA gene in the activation of β-
valine by ATP and CoA.
To determine the substrate range of BvaA-His, the ligase
activity was tested using a wide range of substrates (see
“Materials and methods”). Samples were analyzed by
UPLC-MS for the production of an acyl-CoA. This revealed
a minor activity with 3-aminobutyrate and β-alanine as possi-
ble substrates. However, adduct formation was much lower in
comparison with the formation of β-valine-CoA. Note that
CoA activation of the rest of the tested substrates, including
several fatty acids and phenylacetic acid, was below the level
of the detection. This suggests that BvaA is not a fatty acyl-
CoA ligase or a phenylacetate CoA ligase.
Characterization of BvaB1 and BvaB2
In order to analyze whether the putative β-valinyl-CoA am-
monia lyases encoded by ORF9 and ORF12 are able to con-
vert β-valinyl-CoA to 3-methyl-crotonyl-CoA, enzyme assays
were performed. C-terminal His6-tag versions of both putative
Table 1 List of ORFs identified in the 26-kb insert of p4-D1
ORF Position in the
insert (bp)
Enzyme Seq. identity to known proteins
(%, organism)
EC number PDB ID
1 1429-245 Acetoacetyl-CoA thiolase 49, Clostridium difficile 2.3.1.16 4E1L
2 2204-1530 Gluathione S-transferase 28, Pseudomonas aeruginosa 2.5.1.18 4ECI
3 3132-2215 Hydroxymethylglutaryl-CoA lyase 75, P. aeruginosa 4.1.3.4 2FTP
4 5114-3129 3-methyl-crotonyl-CoA carboxylase 72, P. aeruginosa 6.4.1.4 3U9S
5 6024-5230 Putative enoyl-CoA hydratase 46, Legionella pneumophila 4.2.1.18 3I47
6 7644-6037 3-methylcrotonyl-CoA carboxylase 83, P. aeruginosa 6.4.1.4 3U9R
7 8228-9607 Amino acid transporter 23, Escherichia coli 3L1L
8 (BvaA) 9669-11069 Phenylacetate CoA ligase 36, Burkholderia cenocepacia 6.2.1.30 2Y4N
9 (BvaB1) 11069-11830 Enoyl-CoA hydratase 36, Thermus thermophilus 4.2.1.17 3HRX
10 11909-13690 Transcriptional regulator 46, Vibrio cholerae 4QHS
11 13735-15249 Acetyl-CoA acetyltransferase 30, Mycobacterium smegmatis 2.3.1.9 4EGV
12 (BvaB2) 15234-16034 Enoyl-CoA hydratase 48, Mycobacterium avium 4.2.1.17 3R0O
13 17509-16919 D-2-hydroxyacid dehydrogenase 48, Klebsiella pneumoniae 1.1.99.6 4 N18
14 18807-17827 Cre recombinase 25, Enterobacteria phage P1 1PVP
15 18989-19957 Putative integrase
16 22807-20390 Hypothetical protein
17 24375-23119 Hypothetical protein
18 25616-24588 Hypothetical protein
Fig. 2 aMS spectrum of the single protonated form of β-valinyl-CoA (m/z of 866) and CoA (m/z of 767). bHPLC analyses monitoring the formation of
AMP and β-valinyl-CoA by BvaA-His in time. Lines: ♦, AMP; ♦, ADP; ♦, ATP. Dotted lines: , β-valinyl-CoA; , CoA
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β-valinyl-CoA ammonia lyases, named BvaB1-His (ORF9)
and BvaB2-His (ORF12), were expressed in E. coli. Proteins
of the expected size were present in the soluble fraction.
Enzyme purification using Ni-NTA resin resulted in 160 mg
BvaB1-His and 14 mg BvaB2-His per liter of culture.
For the detection of the expected product 3-methyl-croto-
nyl-CoA, UPLC-MS analysis was performed on samples con-
taining ATP, CoA, β-valine, BvaA-His, and either BvaB1-His
or BvaB2-His. After 16 h of incubation at 30 °C, the presence
of a parent ion with the expected size in a single protonated
form was detected (Fig. 4a). This parent ion was observed in a
mixture containing either BvaB1-His or BvaB2-His but not in
a blank reaction without enzyme. These data reveal that both
expected β-valinyl-CoA ammonia lyases are able to convert
β-valinyl-CoA to 3-methyl-crotonyl-CoA.
To determine the specific activity of BvaB1-His and
BvaB2-His, β-valinyl-CoA and 3-methyl-crotonyl-CoA
levels were monitored in time by HPLC (Fig. 4b). This re-
vealed that approximately 40 % of the available β-valinyl-
CoA is converted to 3-methyl-crotonyl-CoA in the mixture.
This degree of conversion was independent of the β-valinyl-
CoA ammonia lyase used in the assay, suggesting an equilib-
rium. Calculation of the specific activity revealed similar rates
for both lyases, approximately 1.5 U/mg for BvaB1-His and
0.9 U/mg for BvaB2-His.
Discussion
This work investigated the β-valine degradation pathway in
Pseudomonas species strain SBV1 with the overarching goal
to obtain insight in the conversion of β-amino acids that can-
not be deaminated by common aminotransferases, oxidase or
dehydrogenase reactions. The results demonstrate that the key
enzymes for the deamination of β-valine are a CoA-dependent
ligase that activates β-valine and β-valinyl-CoA ammonia ly-
ase that deaminates the product. These reactions result in the
formation of free ammonia and 3-methyl-crotonyl-CoA, a
common intermediate of the leucine degradation pathway
(Massey et al. 1976).
For the identification of the genes involved in β-valine
degradation by P. fluorescens SBV1, a closely related strain
(P. fluorescens pf0-1) unable to grow on medium containing
β-valine as a sole nitrogen source was used as a host for
complementation of its β-valine growth deficiency with a
cosmid gene library. This unveiled the identification of the
bvaA, bvaB1, and bvaB2, genes that encode a CoA ligase
(BvaA) and two CoA ammonia lyases (BvaB1 and BvaB2).
Fig. 3 Conversion of β-valine to β-valinyl-CoA by cell-free extracts of
cells grown on medium supplemented with β-valine and ammonium
sulfate as nitrogen sources. Relative β-valinyl-CoA levels in the
samples were analyzed after 0, 2, and 4 h of incubation using HPLC,
where β-valinyl-CoA levels in SBV1 cell extracts after 2 h incubation
was set at 100 %. Pf-WT β-valine growth-deficient strain Pseudomonas
fluorescens Pf0-1, Pf-Comp P. fluorescens Pf0-1 containing the bvaA
gene on the complementing plasmid p4-D1, SBV1 β-valine-degrading
organism described in this study
Fig. 4 Identification of β-valinyl-CoA ammonia lyase product. a MS
spectrum of the single protonated form of 3-methyl-crotonyl-CoA (m/z
849). b Conversion of β-valinyl-CoA (open black symbols) and
formation of methyl-crotonyl-CoA (closed grey symbols) by purified
BvaB1-his in time as monitored by HPLC
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BLASTsearches using the protein sequence of BvaA dem-
onstrated sequence similarity to several phenylacetate CoA
ligases, enzymes that catalyzes the conversion of phenylacetic
acid to phenylacetyl-CoA (EC 6.2.1.30). In vitro characteriza-
tion of BvaA revealed that this enzyme is indeed able to con-
vert β-valine to β-valinyl-CoA in an ATP- and CoA-
dependent manner. Interestingly, comparison of the biochem-
ical properties of BvaA to different phenylacetate CoA ligases
indicates a completely different substrate scope (Koetsier et al.
2009; Martinez-Blanco et al. 1990). The substrate range of
BvaA is narrow, accepting only β-valine as a substrate and
to a lesser extent 3-aminobutyrate. Phenylacetic acid, fatty
acids, α-amino acids, and other β-amino acids such as β-ly-
sine, were not converted. This observation suggests that BvaA
does not functionally belong to the group of phenylacetyl-
CoA ligases.
BvaA revealed a high sequence identity to the published
B. cenocepacia phenylacetate CoA ligases, PaaK1 and
PaaK2, which belong to the two-domain acyl-CoA ligases
(Law and Boulanger 2011). Structural analyses of Paak1 and
PaaK2 in complex with either ATP or phenylacetyl adenylate
revealed several important residues for proper activity (PDB
codes: 2Y27, 2Y4O, 2Y4N; Law and Boulanger 2011).
Sequence alignments using the identified β-valinyl CoA li-
gase, PaaK1 and PaaK2 demonstrated that the ATP-binding
pocket is present in the identified β-valinyl CoA ligase. To
understand why the characterized β-valinyl-CoA ligase could
not convert phenylacetic acid, a homology model of BvaA
was inspected (see “Materials and methods”). Comparisons
were made with 2Y4N, which is the crystal structure of
PaaK1 in complex with phenylacetyl-CoA (Law and
Boulanger 2011). The modeling indicates that the binding site
is still present, but that the residues immediately lining the
phenyl/β-valine binding site are partially altered. The follow-
ing differences were observed (Y136 (BvaA)→L167
(Paak1), F141→W172, A147→D178, A214→G245,
I236→N270, and Pro245→Ile278). This large number of
differences in residues that contact the phenyl ring in Paak1
(2Y4N) likely results in differences in shape and polarity of
the substrate-binding site that explain why the phenyl sub-
strate is not converted by the identified BvaA.
Characterization of the CoA-ammonia lyases suggest that
both BvaB1 and BvaB2 belong to a new type of CoA-
dependent ammonia lyases with some functional redundancy.
Both enzymes are able to convert β-valinyl-CoA to 3-
methylcrotonyl-CoA in vitro with a similar specific activity.
Additionally, they display significant sequence homology to
each other, but no remarkable similarity to other described
CoA-dependent ammonia lyases, such as the Clostridium
propionicum β-alanyl-CoA lyases (Herrmann et al. 2005).
BLASTsearches using the protein sequences of BvaB1 and
BvaB2 demonstrated high sequence identity to enoyl-CoA
hydratases (EC 4.2.1.17), a class of enzymes that catalyze
the reversible hydration of the double bond of a 2-enoyl-
CoA thioester, resulting in the formation of a β-
hydroxyacyl-CoA thioester (Agnihotri and Liu 2003).
Homologymodels of BvaB1 and BvaB2 were created in order
to rationalize why BvaB1 and BvaB2 are able to catalyze the
deamination of β-valinyl-CoA, while the closely related enoyl
hydratases perform a dehydration reaction. The models were
based on the published crystal structure of the rat liver mito-
chondrial enoyl-CoA hydratase that was complexed with the
inhibitor acetoacetyl-CoA (1DUB; Engel et al. 1996), an
enoyl-CoA hydratase with homology to both BvaB1 (30 %
identity) and BvaB2 (37 % identity). These homology models
indicated that the active sites are highly similar (Fig. 5).
Residues Glu144 and Glu164, which form hydrogen bonds
with the hydroxyl group that is eliminated in enoyl hydratases,
are conserved in BvaB1 and BvaB2 (BvaB1 E113 and E133;
BvaB2 E120 and E140). Interestingly, the modeling of the
active sites of the ammonia lyases predicts that they have an
additional hydrogen bond acceptor, i.e., the backbone carbon-
yl oxygens of Phe139 and Ile146 in BvaB1 and BvaB2, re-
spectively. This is in agreement with a hydroxyl group donat-
ing only one hydrogen bond and an uncharged amino group
donating two hydrogen bonds. The MD simulations predict
Fig. 5 Active site geometries of (a) rat liver mitochondrial enoyl-CoA
hydratase (PDB 1DUB) with modeled 3-amino-butyryl-CoA (orange)
and BvaB1 b and BvaB2 c models with β-valinyl-CoA (yellow)
docked. Only the aminoacyl part of the thioester of the substrate is
shown, with the sulfur in yellow and the amino group to be eliminated
in blue. The active-site residues potentially forming hydrogen bonds are
indicated. Note that in 1DUB a, the distance for a third hydrogen bond is
too Long. Distances in Ångström
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that the carbonyl oxygens of Phe139 and Ile146 indeed accept
a hydrogen bond from the substrate amine group. This hydro-
gen bond is not present in the MD simulation of the rat enoyl-
CoA hydratase with a modeled amine substrate, which might
explain why BvaB1 and BvaB2 are CoA ammonia lyases
instead of hydratases. The formation of the third hydrogen
bond in the MD simulations of BvaB1 and BvaB2 seems to
transpire from a change in the backbone of a loop region
containing residues 168 to 177. The rat enoyl-CoA hydratase
contains a proline at position 170, which is absent in BvaB1
and BvaB2, which may cause minor backbone changes that
prevent formation of the third hydrogen bond in the rat enoyl-
CoA hydratase.
A similar difference in H-bonding pattern appears to deter-
mine the substrate specificities of the well-studied enzymes
aspartase (aspartate ammonia lyase) and fumarase (fumarate
hydratase), which catalyze the addition of respectively ammo-
nia or water to fumarate, resulting in aspartate or malate, re-
spectively. In the literature it is described that also these en-
zymes are structurally very similar and share similar active site
architecture (Puthan Veetil et al. 2012). Visual inspection of
the solved X-ray structures (1FUO and 3R6V) show that, in
the case of fumarase, a water molecule is tightly positioned
with an unusually low B-factor (Weaver and Banaszak 1996).
This water makes three H-bonds, twice as an H-bond donor
(to Asn 141 and His 188) and once as an H-bond acceptor for
Ser98. In aspartase (Fibriansah et al. 2011), the His and Asn
are conserved but Ser98 has been replaced by an alanine,
eliminating the only H-bond donor to the water. At the same
time, in aspartase, Thr 101 can act as a H-bond acceptor for the
ammonia, allowing its H-bonding potential to be fully satis-
fied while binding in a suitable orientation for catalysis to
occur (data not shown).
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